Corrigendum: Downregulation of ATXN3 enhances the sensitivity to AKT inhibitors (Perifosine or MK-2206), but decreases the sensitivity to chemotherapeutic drugs (etoposide or cisplatin) in neuroblastoma cells

Detalles Bibliográficos
Autores principales: Gong, Baocheng, Zhang, Jinhua, Hua, Zhongyan, Liu, Zhihui, Thiele, Carol J., Li, Zhijie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382292/
https://www.ncbi.nlm.nih.gov/pubmed/35992874
http://dx.doi.org/10.3389/fonc.2022.984514

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9382292/
https://www.ncbi.nlm.nih.gov/pubmed/35992874
http://dx.doi.org/10.3389/fonc.2022.984514

Ejemplares similares